Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Launch Of Zoledronic Acid Injection


Monday, 4 Mar 2013 01:49pm EST 

Dr.Reddy's Laboratories Ltd announced that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa (zoledronic acid) 4 mg/5 mL Injection in the US market on March 4, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Zoledronic Acid Injection (4 mg/5 mL). Dr. Reddy’s Zoledronic Acid Injection 4 mg/5mL is available in a single use vial of concentrate. 

Company Quote

3525.05
-5.0 -0.14%
4:59am EST